SPDR S&P Biotech (Xbi) Shares Bought by Winfield Associates Inc.


Winfield Associates Inc. increased its holdings in shares of SPDR S&P Biotech by 22.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 29,400 shares of the exchange traded fund's stock after acquiring an additional 5,335 shares during the period.



from Biotech News